 |
|
Aquisition Of Hepatitis-Associated AntigenClinical Features in Young Adults
Lewellys F. Barker, MD;
Roderick Murray, MD
JAMA. 1971;216(12):1970-1976.
Abstract
Twelve participants in studies on inactivation of the agent of serum hepatitis in blood and blood products, which were conducted in 1951 to 1954, became persistent carriers of the Australia or hepatitis-associated antigen (HAA). In eight of the 12, their inoculation with various icterogenic materials resulted in illness of minimal severity. Four others had no recognizable clinical illness. Of the 12, ten had follow-up examinations from one to three years later, and all were thought to have either probable or definite evidence of minimal residual hepatic dysfunction at that time. This group of 12 differs from 103 individuals in whom transient serum HAA developed. Most members of the latter group had more severe initial illness, but only 16 of 72 were thought to have evidence of residual hepatic dysfunction on follow-up examination.
Author Affiliations
From the Division of Biologics Standards, National Institutes of Health, Bethesda, Md 20014.
Footnotes
Reprint requests to 9000 Rockville Pike, Bethesda, Md 20014 (Dr. Barker).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
The Duration of Hepatitis B Surface Antigenemia
Sampliner
Arch Intern Med 1979;139:145-146.
ABSTRACT
Prevention of Nosocomial Viral Hepatitis, Type B (Hepatitis B)
SNYDMAN et al.
ANN INTERN MED 1975;83:838-845.
ABSTRACT
{alpha}1-Fetoprotein and Liver-Specific Antigen in Viral Hepatitis Type B
Smith and Barker
Arch Intern Med 1974;133:437-439.
ABSTRACT
Hepatitis B Antigenemia in Apparently Healthy Blood Donors
Griffin
JAMA 1973;226:753-755.
ABSTRACT
Antibody Responses in Viral Hepatitis, Type B
Barker et al.
JAMA 1973;223:1005-1008.
ABSTRACT
Duration of Incubation for Serum Hepatitis And Severity of the Disease
Allen
JAMA 1971;218:444-445.
ABSTRACT
|
